Menglu Zhu

734 citations
29 papers · 557 indexed · h-index 15
Topics
Nanoparticle-Based Drug Delivery (5 papers)Nanoplatforms for cancer theranostics (5 papers)Enzyme Catalysis and Immobilization (3 papers)
Partner nations
ChinaJapanCzechia

In The Last Decade

Menglu Zhu

25 papers receiving 554 citations

Peers

Menglu Zhu
Comparison fields: 5 of 99
  • Molecular Biology 204
  • Biomedical Engineering 160
  • Biomaterials 100
  • Endocrinology, Diabetes and Metabolism 98
  • Materials Chemistry 62
Replace Gabriela Kolláriková with:
Gabriela Kolláriková Slovakia
Shaymaa Mousa United States
J. Narayanan India
Kai Guo China
Mehrafarin Fesharaki Iran
Zhijue Xu China
Binhua Zou China
Rajendra Kumari United Kingdom
Si Wang China
Menglu Zhu relative to Gabriela Kolláriková Slovakia Gabriela Kolláriková's profile →
Citations per field
00.5×10.5×
Gabriela Kolláriková · 1×
Citations per year

Countries citing papers authored by Menglu Zhu

Since Specialization
Citations

This map shows the geographic impact of Menglu Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menglu Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menglu Zhu more than expected).

Fields of papers citing papers by Menglu Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menglu Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menglu Zhu. The network helps show where Menglu Zhu may publish in the future.

Co-authorship network of co-authors of Menglu Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Menglu Zhu. A scholar is included among the top collaborators of Menglu Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menglu Zhu. Menglu Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 1
6 7
7 14
8 1
9 82
10 4
11 52
12 45
13 45
14 7
15 51
16 18
17 26
18 35
19 32
20 25

About Menglu Zhu

Menglu Zhu is a scholar working on Biomaterials, Immunology and Allergy and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 557 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Enzyme Catalysis and Immobilization (3 papers). The work is most often cited by research in Biomaterials (100 citations), Endocrinology, Diabetes and Metabolism (98 citations) and Pharmaceutical Science (28 citations). Menglu Zhu has collaborated with scholars based in China, Japan and Czechia. Frequent co-authors include Hui‐Min Qin, Fuping Lu, Zhangliang Zhu, Xiaoling Xu, Xin Liu, Yongzhong Du, Ying Chen, Chao Li, Kong-jun Lu and Jing Qi. Their work appears in journals such as Journal of Agricultural and Food Chemistry, ACS Catalysis and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026